期刊文献+

性激素与原发性尿路结石形成关系的研究 被引量:4

Research on the relationship between sex hormones and primary urinary stone formation
原文传递
导出
摘要 目的:探讨性激素与原发性尿路结石形成的关系,尿路结石发病性别差异的原因以及外源性使用雌激素药物的安全性。方法:将我院1995年3月-2014年3月诊治的355例符合入组标准的患有尿路结石及同质的未患有尿路结石的患者纳入本研究,清晨空腹、安静状态下分别采取各组患者的肘静脉血液送检,采用化学发光法分别测取送检标本的雌二醇(E2)、睾酮(T)、孕酮(Prog)、催乳素(PRL)、黄体生成激素(LH)、卵泡刺激素(FSH),对比分析。结果:E2、T、Prog、PRL、LH、FSH在各组中差异均有统计学意义,但卵泡刺激素在男性组中差异不显著。结论:1雌性激素可能对原发性尿路结石有一定的抑制作用,而睾酮可能促进尿路结石的形成;2适度使用外源性雌激素药物治疗及预防尿路结石尤其是绝经后女性患者的尿路结石是有效的。 Objective: To investigate the causal relationship between sex hormone and primary urinary stone formation, the cause of gender differences in urinary tract stone formation and the safety of exogenous estrogen drugs. Method: From March 1995 to March 2014, 355 cases were studied including patients diagnosed as urinary tract stones and other homogeneous patients who were not diagnosed as urinary tract stones. Each patient was taken elbow venous blood samples when they fast and were under quiet state in the morning. Chemiluminescence method was used to measure estradiol (E2), testosterone (T), progesterone (Prog), prolactin (PRL), luteinizing hormone (LH), and follicle stimulating hormone (FSH) in each sample, and related data were comparatively analysed. Result: E2, T, Prog, PRL, LH, FSH showed statistically significant in each group, but the difference of FSH in male group was not significant. Conclusion: ①Female hormones may have inhibitory effect on primary urinary stones, but testosterone may promote the formation of urinary calculi. ②A rational use of exogenous estrogen in treatment and prevention of urinary calculi is effective especially in postmenopausal women.
出处 《临床泌尿外科杂志》 2015年第12期1096-1099,1104,共5页 Journal of Clinical Urology
基金 上海市虹口区卫计委医学科研课题(编号虹卫1303-04)
关键词 尿路结石 雌二醇 睾酮 孕酮 催乳素 黄体生成素 卵泡刺激素 urinary tract stone estradiol testosterone progesterone prolactin luteinizing hormone follicle-stimulating hormone
  • 相关文献

参考文献16

  • 1钟文,曾国华,袁坚,单炽昌,钟惟德.经皮肾镜取石术治疗多次体外冲击波碎石失败肾结石的临床分析[J].中华泌尿外科杂志,2013,34(5):333-336. 被引量:31
  • 2孙颖浩,王林辉,廖国强,许传亮,戚晓升,高旭,杨庆,邱镇,钱松溪.螺旋形双J管在体外冲击波治疗复杂输尿管结石中的应用[J].中华泌尿外科杂志,2002,23(6):338-339. 被引量:114
  • 3Akman T, Binbay M, Sari E, et al. Factors atfecting bleeding during percutan-eous ephrolithotomy: single surgeon experience[J]. J Endourol, 2011, 25(2) :327 --333.
  • 4钱庆鹏,张晓春,那彦群.经皮肾镜取石术的并发症与对策[J].临床泌尿外科杂志,2007,22(7):491-493. 被引量:131
  • 5Turna B, Nazli O, Demiryoguran S, et al. Percutane- ous nephrolithotomy: variables that influence hemor- rhage[J]. Urology, 2007, 69(4): 603--607.
  • 6Zaki H, Nikkar M M, Lashay A, et al. Delayed post- pereutaneous nephrolithotomy hemorrhage:Preva- lence, predictive factors and management [J]. Scand J Urol, 2013, 21(11): 75-78.
  • 7王言奎.合并肾功能异常的围术期处理[J].中国实用妇科与产科杂志,2007,23(2):84-85. 被引量:7
  • 8Srivastava A, Singh K J, Suri A. Vascular complica- tions after precutaneous nephrolithotomy: are there any predictive factors[J]? Urology, 2005, 66(1): 38--40.
  • 9Kukreja R, Desai M, Patel S, et al. Factors affecting blood loss during percutaneous nephrolithotomy: pro- spective study[J]. J Endourol, 2004, 18(8): 715-- 722.
  • 10Yamaguchi A, Skolarikos A, Buchholz N P, et al. Op- erating times and bleeding complications in percutane- ous nephrolithotomy: a comparison of tract dilation methods in 5537 patients in the clinical research office of the endourological society percutaneous nephrolithot- omy global study[J]. J Endourol, 2011, 25(6): 933-- 939.

二级参考文献76

  • 1李建兴,田溪泉,牛亦农,张鑫,康宁.B超引导经皮肾镜气压弹道联合超声碎石术治疗无积水肾结石[J].中华外科杂志,2006,44(6):386-388. 被引量:179
  • 2曾国华,钟文,李逊,陈文忠,杨后猛,袁坚,何朝辉,何永忠,雷鸣,吴开俊.一期多通道微创经皮肾穿刺取石术治疗鹿角状结石[J].中华泌尿外科杂志,2007,28(4):250-252. 被引量:71
  • 3李逊.微创经皮肾穿刺取石术[M]//黄健,李逊.微创泌尿外科学.武汉:湖北科学技术出版社,2005:207-213.
  • 4Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1:AUA guideline on management of staghorn calculi:diagnosis and treatment recommendations. J Urol, 2005, 173:1991-2000.
  • 5Stoller ML, Wolf JSJr, St Lezin MA. Estimated blood loss and transfusion rates associated with percutaneous nephrolithotomy. J Urol, 1994,152: 1977-1981.
  • 6Shaw G, Wah TM, Kellett MJ, et al. Management of renalvein perforation during a challenging percutaneous nephrolithotomy. J Endourol,2005,19:722-723.
  • 7Lahme S, Bichler KH, Strohmaier WE, et al. Minimally in vasive PCNL in patients with renal pelvic and caliceal stones. Eur Urol,2001,40:619-624.
  • 8Smith AD. Percutaneous punctures:is this the endourologist's turf? J Urol,1994,152:1982.
  • 9Buchholz NP. Three-dimensional CT scan stone reconstruction for the planning of percutaneous surgery in a morbidly obese patient. Urol Int,2000,65:46-48.
  • 10Martin X, Tajra LC, Gelet A, et al. Complete staghorn stones:percutaneous approach using one or multiple percutaneous accesses. J Endourol, 1999,13:367-368.

共引文献484

同被引文献48

  • 1陈楠.重视肾结石的诊断及内科治疗[J].中华肾脏病杂志,2004,20(5):380-381. 被引量:28
  • 2叶章群.泌尿系结石研究现况与展望[J].中华实验外科杂志,2005,22(3):261-262. 被引量:268
  • 3何群,张晓春,那彦群.284例泌尿系结石成分分析与代谢评价[J].中华泌尿外科杂志,2005,26(11):761-764. 被引量:97
  • 4叶章群.泌尿系结石成因及防治新进展[J].现代实用医学,2007,19(4):258-261. 被引量:30
  • 5Wu B,Wilmouth R C.Proteomics analysis of immunoprecipitated proteins ass ociated with the oncogenic kinasecot[J].Mol Cells,2008,25(1):43-49.
  • 6Daudon M,Bazin D,Letavernie R E.Randalls plaqueas the origin of calcium oxalate kidneystones[J].Urolithiasis,2015,43(Suppl 1):5-11.
  • 7Laminski N A,Meyers A M,Kruger M,et al.Hyperoxaluriain patients with recurrent calcium oxlatale calculi:dietaryandother risk factors[J].Br J Urol,1991,68(5):454-458.
  • 8Goldenberg I,Matetzky S.Nep Hropathy induced by contrast media:pathogenesis,risk factors and preventive strategies[J].Canadian Medical Association Journal,2005,172(11):1461-1471.
  • 9Atan L,Andreoni C,Ortiz V,et al.High kidneystone risk in men working in steel industry at hot temperatures[J].Urology,2005,65(5):858-861.
  • 10Kabeya Y,Kato K,Tomita M,et al.Associations of insulin resistance and glycemic control with the risk of kidney stone[J].Intern Med,2012,51(7):699-705.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部